higher carbon intensity and concerns around air and water pollution. Relevant companies include ECA , ENB , EEP , STO , XOM , IMO , SU , CVE , PGH , BP , CNQ , BTE , DVN , IVAN , AAV , RDS.A , RDS.B , PTR , OTCPK:ATHOF Post your comment!
This was an excellent overview of the seven top investment mistakes IMO , particularly the one called "anchoring" which I hadn't heard of before although had stumbled in that area several times
CCJ ), E.ON SE ( OTCQX:EONGY ), RWE AG ( OTCPK:RWEOY ), Areva ( OTCPK:ARVCF ), Suncor Energy ( SU ), Imperial Oil ( IMO ), Exxon ( XOM ), and Royal Dutch Shell (RDSA, RDSB) by Levis Kochin April 8, 2014 INTRODUCTION Silex - a
allocation should be driven by the requirement to minimize possibility of falling short in retirement, rather than usual MPT considerations, and (ii) should use active allocation to minimize those odds of falling short. Really good article, IMO .
by Idera ( IDRA ) demonstrates the ability of the company's IMO -8400 drug to "inhibit the survival and proliferation of B ..... Idera has opened enrollment for a Phase 1/2 trial to evaluate IMO -8400 for use in treating " patients with Waldenströms macroglobulinemia
My favorite of the various blurbs written in response to Michael Lewis' latest book on HFT. IMO he gets it about right.
interests, and contingency planning for spills and accidents. Energy producers such as Exxon ( XOM ) affiliate Imperial Oil ( IMO ), BP and Suncor ( SU ) are looking to the Trans Mountain expansion and other proposed pipelines - most notably
Imperial Oil ( IMO , XOM ) has spent more than expected in ramping up production at its Kearl oil sands mining operation in Alberta, but CEO Rich
positive phase 2 clinical trial results for it psoriasis drug IMO -8400. The 32-patient study met its primary endpoint of safety ..... assessed by Psoriasis Area and Severity Index (PASI) scores. IMO -8400 has demonstrated activity in other autoimmune diseases
The stock was due for a correction after it ran up almost seven-fold from its July 29 break out. Not helping matters was a bearish report by Summer Street Capital asserting the its lead product, IMO -8400 , is ineffective. 2 comments!